Effects of Maternal and Fetal Characteristics on Cell-Free Fetal DNA Fraction in Maternal Plasma
- 1 November 2015
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 22 (11) , 1429-1435
Abstract
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.Keywords
This publication has 35 references indexed in Scilit:
- Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidiesBMC Medical Genomics, 2012
- Clinical application of massively parallel sequencing‐based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11 105 pregnancies with mixed risk factorsPrenatal Diagnosis, 2012
- Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA SequencingObstetrics & Gynecology, 2012
- Hepatitis B Therapy in PregnancyCurrent Hepatitis Reports, 2010
- Total and Fetal Cell-Free DNA Analysis in Maternal Blood as Markers of Placental Insufficiency in Intrauterine Growth RestrictionFetal Diagnosis and Therapy, 2009
- Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetusesProceedings of the National Academy of Sciences, 2009
- Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities?Prenatal Diagnosis, 2006
- Inverse Correlation Between Maternal Weight and Second Trimester Circulating Cell-Free Fetal DNA LevelsObstetrics & Gynecology, 2004
- Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)Hypertension, 2003
- Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence riskAmerican Journal of Medical Genetics, 1994